Skip to main content

Sawa Ito

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #1,433
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 15175688Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-6076-0234Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Otolaryngology
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$7.3M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#1,433
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Sawa Ito. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$6.4M

2 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Sawa Ito as a PI. Multi-PI records show the full award amount for context.

  • 5P30CA047904-38P30Contact PI
    Cancer Center Support Grant
    University of Pittsburgh · Otolaryngology (NIH department code)
    $6M
    award amount
  • 5R01FD008187-02R01Contact PI
    Phase 2 Study of Interferon-Gamma and Donor Lymphocyte Infusion for the Treatment of Relapsed Myeloid Malignancies after Allogeneic Stem Cell Transplantation
    $853.3K
    award amount
  • 1R21CA307892-01A1R21Contact PI
    Interferon-γ in combination with donor leukocyte infusion to treat relapsed acute myeloid leukemia and myelodysplastic syndromes after haploidentical donor stem cell transplantation
    $408.8K
    award amount

Award organization

Organizations that administered FY2026 awards listing Sawa Ito as a PI.

FY2026 award administered by University of Pittsburgh (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    R01 Grant Holder
  4. 2026
    $1M Cumulative Funding
  5. 2026
    $2M Cumulative Funding
  6. 2026
    $5M Cumulative Funding
  7. 2026
    Entered Top 50% Nationally
    Ranked #1433
  8. 2026
    Entered Top 25% Nationally
    Ranked #1433
  9. 2026
    Entered Top 10% Nationally
    Ranked #1433